Briacell Therapeutics Corp（BCTX）價格預測BCTXBriacell Therapeutics Corp

Alphio's BCTX stock price prediction model matches the current Briacell Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.55 (+0.48%). The 1-week path is $3.41 (-3.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Briacell Therapeutics Corp (BCTX) is currently priced at $3.73, which is significantly lower than its 200-day simple moving average of $4.954, indicating a bearish trend. The stock has a high historical volatility of 137.16%, suggesting potential for large price swings. Although the company has recently made strides in personalized immunotherapy, its net income has been consistently negative, with the latest quarterly loss at -$7,167,507. The forward P/E ratio is not applicable due to negative earnings, and the stock has seen a year-to-date decline of 47.98%. Given these factors, while there are some positive developments, the overall financial health and stock performance suggest holding rather than buying at this time.

Briacell Therapeutics Corp (BCTX) last closed at $3.53, losing -1.12%. These facts feed the 1-day and 1-week BCTX price prediction above.